Wealth Preservation Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-150
Closed -$11.3K – 480
2026
Q1
$11.3K Hold
150
– – 0.01% 398
2025
Q4
$11.9K Hold
150
– – 0.01% 288
2025
Q3
$9.8K Hold
150
– – 0.01% 297
2025
Q2
$5.93K Hold
150
– – ﹤0.01% 342
2025
Q1
$4.53K Buy
+150
New +$4.91K ﹤0.01% 389

Other funds holding IONS

Wealth Preservation Advisors's IONS Position: Q2 2026 in Review

Wealth Preservation Advisors sold out of Ionis Pharmaceuticals (IONS) in Q2 2026, closing a stake of 150 shares — an estimated $11.3K sold.

Wealth Preservation Advisors first reported a position in IONS in Q1 2025 and held it in 5 quarters. The position peaked at $11.9K in Q4 2025. 518 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Wealth Preservation Advisors reported no remaining Ionis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Wealth Preservation Advisors sold 150 Ionis Pharmaceuticals shares in Q2 2026, an estimated $11.3K.
  • Wealth Preservation Advisors first reported a position in Ionis Pharmaceuticals in Q1 2025 and held it in 5 quarters.
  • Wealth Preservation Advisors's Ionis Pharmaceuticals position peaked at $11.9K in Q4 2025.
  • 518 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Wealth Preservation Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.